News Archives - VIPOC

VIPOC

News

17 December 2025

Closing 2025 with Gratitude: VIPOC’s Year of Impact, Reflection, and Forward Momentum

As December unfolds and 2025 draws to a close, VIPOC…

VIPOC 0

Love0

six-year

News

28 November 2025

Celebrating Six Years of Patient-Led Innovation in Vitiligo Treatment and Awareness

As VIPOC marks its six-year milestone, we reflect with pride…

VIPOC 0

Love0

News

28 November 2025

Celebrating VIPOC’s 6th Anniversary: Stories of Resilience and Community Impact

As VIPOC marks its sixth anniversary, we pause to celebrate…

VIPOC 0

Love0

Member Events News

28 July 2025

German Vitiligo Association (Deutscher Vitiligo-Bund e.V.) Inspiring, Informative, and Diverse – The Children’s Vitiligo Days in June 2025

For the second time, the German Vitiligo Association (Deutscher Vitiligo-Bund…

VIPOC 0

Love0

News Vitiligo Advocacy Vitiligo research

30 June 2025

French Medical Study References VIPOC’s White Paper: A Milestone in Global Research Engagement

Still poorly known, poorly understood, and still widely stigmatized, vitiligo…

Marketing 0

Love0

executive board members

Events News Vitiligo Advocacy

30 June 2025

New Leadership, Stronger Voice: VIPOC Announces 2025–2026 Executive Board

June 2025 marked a pivotal moment for VIPOC, the global…

Marketing 0

Love0

News vitiligo treatment

21 October 2024

Incyte Announces Health Canada Approval of OPZELURA® (ruxolitinib) Cream for the Treatment of Atopic Dermatitis (AD) and Nonsegmental Vitiligo

News provided by Incyte Biosciences Canada - First and only…

VIPOC 0

Love0